(PharmaNewsWire.Com, February 28, 2017 ) Publisher's "Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Size Forecast-2020" Reports provides an overview of the disease and global market size of the Nonalcoholic Steatohepatitis (NASH) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Nonalcoholic Steatohepatitis (NASH) from 2010-2020.Steatohepatitis (also known as fatty liver disease) is a type of liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. NASH affects 2 to 5 percent of Americans. An additional 10 to 20 percent of Americans have fat in their liver, but no inflammation or liver damage, a condition called "fatty liver."Most people with NASH are between the ages of 40 and 60 years. Up to 25% of adults with NASH may have cirrhosis. Priorities for future research are the optimization of non-invasive screening strategies, the identification of patients at risk of liver disease progression, the understanding of the hepatic carcinogenic potential and testing innovative pharmacological targets for therapy.
- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. - Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018. - The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020. - It also provides Market size of Nonalcoholic Steatohepatitis (NASH) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
- Nonalcoholic Steatohepatitis (NASH) - Disease overview: - Pathophysiology: - Symptoms of disease: - Etiology of disease - Diagnosis of disease - Treatment of disease - Overview of Marketed drugs - Drug Description - Mechanism of Action - Pharmacokinetics Properties - Marketed Details - United States - Patent Information - Patent Exclusivity Expiry Assessment United States (US) - Patents Details - Historical and Forecasted sales of marketed molecules in the Global Nonalcoholic Steatohepatitis (NASH) Market - Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) Forecasted to 2020 - Global Market size (2011-2014) - Global Forecasted Market size (2015-2020) - Global Market Size by Geography - Market size of US (2011-2014) - Forecasted Market size of US (2015-2020) - Market size of Europe - Market size of Germany (2011-2014) - Forecasted Market size of Germany (2015-2020) - Market size of United Kingdom (2011-2014) - Forecasted Market size of United Kingdom (2015-2020) - Market size of France (2011-2014) - Forecasted Market size of France (2015-2020) - Market size of Italy (2011-2014) - Forecasted Market size of Italy (2015-2020) - Market size of Spain (2011-2014) - Forecasted Market size of Spain (2015-2020) - Market size of Japan (2011-2014) - Forecasted Market Size of Japan (2015-2020) - Market size of ROW (2011-2014) - Forecasted Market size of ROW (2015-2020) - Appendix - Report Methodology - Consulting Services - Disclaimer - Report Purchase Options - About DelveInsight
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
